ABP-1618
N/A
Report date: 2024/06/04 16:17:03
NME
Base Information
Drug NameABP-1618
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Aibo Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesShanghai Aibo Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A